Press-release for stocks related to fda

Prices are updated after-hours

| -98.56% | O: 0.5% H: 0.33% C: -3.67%
approval fda granted cancer prostate cancer grant

FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%)
Published: 2021-06-11 (Crawled : 18:03) - fda.gov
A | $137.89 3.02% 420K

| -6.4% | O: 0.21% H: 0.17% C: 0.12%
approval fda fda approval nivolumab

Adial to File Fast Track Application for AD04 with the FDA
Published: 2021-02-23 (Crawled : 18:03) - globenewswire.com
ADIL | News | $1.75 -7.9% 220K

| -38.31% | O: -2.92% H: 7.02% C: 4.68%
fda fast track application

87%

13%

MTTR | News M | $4.595 164.08% 13M

AGBA | $2.355 88.4% 34M

EDBL | News | $6.75 79.52% 1.5M

CZOO | $8.77 75.75% 11M

MTC | $2.28 46.15% 2.6M

OPRT | News | $3.14 39.56% 7.6M

VNRX | $0.8 33.33% 2.9M

MLEC | $1.865 33.21% 2.4M

PALI | $6.37 29.21% 21M

CMAX | $4.12 28.35% 65K

Save your searches and get alerts when important news are released.